• Hydroxychloroquine Sulfate: Technical Guide for Autoimmune R

  2026-07-09

  Hydroxychloroquine Sulfate (SKU B4874) is designed for researchers studying immune modulation, particularly in systemic lupus erythematosus and rheumatoid arthritis models. It is effective for inhibiting autophagy and TLR7/9 signaling in aqueous-based experiments, but should not be used in protocols that require organic solvent compatibility or long-term solution storage.

• EdU Imaging Kits (488): Next-Generation Cell Proliferation I

  2026-07-09

  Discover how EdU Imaging Kits (488) empower high-fidelity measurement of S-phase DNA synthesis using 5-ethynyl-2'-deoxyuridine, and learn how advanced click chemistry is transforming cell proliferation assays in cancer and immunology research.

• GSK-923295: A Potent CENP-E Inhibitor for Mitotic Arrest

  2026-07-08

  GSK-923295 is a highly selective small-molecule CENP-E inhibitor that induces robust cell cycle arrest in mitosis and demonstrates dose-dependent antitumor activity in colon cancer xenograft models. Its precise mechanism and verifiable benchmarks make it a valuable tool for dissecting chromosome alignment regulation and mitotic checkpoint fidelity in cancer research.

• Red Blood Cell Lysis Buffer: Optimizing Mammalian Sample Pre

  2026-07-08

  Red Blood Cell Lysis Buffer (K1169) from APExBIO empowers researchers with selective, high-yield erythrocyte removal, enabling precise blood sample preparation for flow cytometry, nucleic acid, and protein extraction workflows. Dive into experimental strategies, troubleshooting insights, and advanced use-cases that maximize cell recovery and data reliability.

• Protease Inhibitor Cocktail (MS-SAFE, 50X in DMSO): Practica

  2026-07-07

  The Protease Inhibitor Cocktail (MS-SAFE, 50X in DMSO) is designed to prevent protein degradation during extraction, particularly for workflows requiring mass spectrometry compatibility. It is not formulated for applications where metalloproteinase inhibition is critical unless supplemented with EDTA, and should be avoided in workflows sensitive to DMSO.

• PD98059: MEK Inhibitor Workflows for Cancer & Neuroprotectio

  2026-07-07

  PD98059 is a proven, selective MEK inhibitor that empowers researchers to dissect the MAPK/ERK pathway with precision, enabling breakthroughs in both cancer and neuroprotection models. This article delivers actionable protocols, troubleshooting strategies, and advanced assay guidance to maximize the utility of PD98059 from APExBIO in translational research.

• JNJ-26854165 (Serdemetan): Optimizing p53-Driven Cancer Rese

  2026-07-06

  JNJ-26854165 (Serdemetan) is a potent anti-proliferative agent and apoptosis inducer uniquely suited for dissecting p53 pathway biology and radiosensitization in tumor models. This guide delivers advanced experimental workflows, troubleshooting strategies, and practical protocol enhancements to help researchers fully leverage Serdemetan’s mechanistic precision in cancer research.

• Transcriptomic Impacts of Housing on Laying Hen Hypothalamus

  2026-07-06

  This study applies transcriptomic profiling to reveal how caged versus cage-free housing systems distinctly modulate hypothalamic gene expression in laying hens, especially in relation to stress and metabolic pathways. The findings highlight the value of molecular approaches for assessing poultry welfare under commercial conditions.

• Spatially Targeted mTORC1 Inhibition Uncovers Nuclear Functi

  2026-07-05

  This study introduces TerminaTOR, a genetically encoded inhibitor enabling selective mTORC1 inhibition at defined subcellular compartments. By revealing distinct nuclear mTORC1 roles in transcriptional regulation, the research advances understanding of PI3K/Akt/mTOR pathway compartmentalization and its impact on gene control.

• iRhom2 in Olfactory Sensory Neurons: Mechanisms and Adaptati

  2026-07-04

  Azzopardi et al. reveal that iRhom2, previously considered largely absent in the mouse brain, is uniquely expressed in olfactory sensory neurons where it modulates odorant receptor gene expression and activity-dependent adaptation. This mechanistic insight broadens our understanding of olfactory system regulation and offers new experimental angles for sensory biology research.

• Amitriptyline HCl: Lipid Signaling Insights for Neuropharmac

  2026-07-03

  Explore how Amitriptyline HCl advances neuropharmacology research through unique modulation of lipid and neurotransmitter pathways. This article uncovers fresh mechanistic perspectives and assay strategies, distinct from prior coverage.

• Dual-Action Inhibition Modulates p38α MAPK Dephosphorylation

  2026-07-03

  The reference study reveals that certain ATP-competitive inhibitors, including indole-5-carboxamide derivatives, not only inhibit p38α MAP kinase activity but also accelerate its dephosphorylation by stabilizing a specific inactive conformation. This dual-action mechanism suggests new strategies for designing potent and selective p38 MAPK inhibitors with significant implications for inflammation, diabetes, and neuroregeneration research.

• Annexin V, Human Recombinant: Precision Tools for Apoptosis

  2026-07-02

  Explore how Annexin V, a leading phosphatidylserine binding protein, enables advanced apoptosis assays and metabolic studies in cancer research. This article uniquely connects phosphatidylserine externalization to metabolic reprogramming, guiding assay design beyond standard protocols.

• Localized Delivery of Olaparib Nanoparticles via Hydrogel in

  2026-07-02

  This study introduces a sprayable, bioadhesive hydrogel embedding etoposide and olaparib (AZD2281) nanoparticles for localized post-surgical delivery to glioblastoma. The approach demonstrates preclinical feasibility, stable drug release, and tissue penetration—potentially overcoming blood-brain barrier limitations and enhancing tumor radiosensitization strategies.

• Olaparib (AZD2281): Precision Tools for BRCA-Deficient Cance

  2026-07-01

  Olaparib (AZD2281) empowers targeted DNA damage response assays and tumor radiosensitization studies, particularly in BRCA-deficient and homologous recombination repair-impaired cell models. Leverage the latest workflows, protocol enhancements, and troubleshooting strategies to maximize experimental clarity and translational relevance with APExBIO's trusted formulation.

16632 records 1/1109 page Next 12345 下5页 Last page